chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A red, itchy, slightly raised rash allover legs and torso; A red, itchy, slightly raised rash allover legs and torso; slightly raised rash all over my legs and torso; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in right arm on 01Apr2021 at 12:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included ADHD, female pattern baldness (hair loss), and obesity. Concomitant medications included amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL), minoxidil (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D), melatonin (MELATOL), and vitamins nos (MULTIVITAMIN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced a red, itchy, slightly raised rash all over legs and torso, that became worse when scratched or overheat. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. On 06Apr2021, the patient underwent COVID-19 virus test  (Nasal Swab) and the result was negative. On 13Apr2021, the patient underwent COVID-19 virus test (Nasal Swab) and the result was pending. The clinical outcome of the events red, itchy, slightly raised rash all over legs and torso, that became worse when scratched or overheat was not recovered.  No follow-up attempts are needed. No further information is expected.
Constipation, lethargic 24-72 hours onset after vaccine administered.  Vomiting, diarrhea, nausea, cramping, bodyaches onset 72 hours to present time.
7/30/13: Given VZV and MMR in R thigh. Had temp about 2 wks later, treated supportively. 10/7/13: Had clinical Hand, Foot, Mouth, treated supportively. 11/1/13: Pentacel and Flu in R thigh. 11/10/13: Developed collection of yellow/whitish bumps on erythematous base at site of previous injection.  Further collections ranging from 3-9 in number of bumps developed over next few days, totalling 7 separate clusters in general distribution of the L3/L4 dermatome along the upper outer R thigh, extending down anteriorly and medially to include the inner R knee area.  Throughout eruption of the lesions has remained afebrile, eating/sleeping/behaving normally.  Mom denies any pruritis or noted discomfort of the lesions.
I would like to note that I have always had a very regular monthly menstrual cycle where my period was no greater than 7 days. I started my  period the day I got the Pfizer COVID19 vaccine. I noticed my period lasted for a total of 12 days instead of the usual 7 days. My menstrual period was also lighter than usual.
Small hives in strange parts of the body (opposite arm from shot, belly, inner thigh. Not a rash-- just isolated hives, about five in total. the The specific hives, in a quantity as large as 5 in disparate areas, is unusual for me
This case was reported by a healthcare professional and described the occurrence of diaphoresis in a subject of unspecified age and gender who was vaccinated with FLULAVAL, GlaxoSmithKline.  On an unspecified date the subject received unspecified dose of FLULAVAL (unknown).  At an unspecified time after vaccination with FLULAVAL, the subject experienced diaphoresis, chest pain, shortness of breath and fatigue.  The healthcare professional considered the events were life threatening and clinically significant (or requiring intervention).  At the time of reporting the outcome of the events was unspecified.  Four additional subjects had similar symptoms.  Linked cases include: A0751890A, A0751892A, A0751894A and A0751895A.  Linked case A0751880A was more severe and included subject and event specifics.
Total body rash with white papules on arms and legs starting about 1 hr after injection. First course of vaccine tolerated well on 5/24/18.
joint pain; This is a spontaneous report from a contactable consumer (patient). This female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on 16Dec2020 between 12:30 and 1:30 for COVID-19 immunisation. Medical history and concomitant medication were not reported. She got the first vaccine on the 16Dec2020 between 12:30 and 1:30 and had symptoms 12 to 13 hours post injection. She had joint pain which was normal. She didn't think it was necessary to call about that. The outcome of event was unknown.   Information about Lot/Batch number is requested.
large hardness at the injection site; Injection site warm to the touch; Injection site red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (large hardness at the injection site), VACCINATION SITE WARMTH (Injection site warm to the touch) and VACCINATION SITE ERYTHEMA (Injection site red) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE MASS (large hardness at the injection site), VACCINATION SITE WARMTH (Injection site warm to the touch) and VACCINATION SITE ERYTHEMA (Injection site red). The patient was treated with IBUPROFEN for Vaccination site lump, Vaccination site erythema and Vaccination site warmth, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE MASS (large hardness at the injection site), VACCINATION SITE WARMTH (Injection site warm to the touch) and VACCINATION SITE ERYTHEMA (Injection site red) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient treated symptoms with ice.
no additional AEs; Caller reports that MMR II lot expired on 10/08/22 and was administered on 10/11/22; This spontaneous report was received from a clinical administrator and refers to a 9-year-old patient of unknown gender. No information regarding patient's pertinent medical history, drug reactions, allergies and concomitant medications was reported.  On 11-OCT-2022, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin (rHA)) (M-M-R II) subcutaneous injection, at a dose of 0.5 ml, once, lot # T034391 with expiration date of 08-OCT-2022 for prophylaxis (dose #, route of administration and anatomical location were not provided). No adverse event was reported.; Sender's Comments:  US-009507513-2210USA004126: US-009507513-2210USA004097:
Menstruation began at a typical time (not early or late in the cycle) but bleeding lasted 18 days. Typical length of bleeding for me is 4 days. The bleeding was not heavier than usual. At the two week mark, I visited a doctor, who asked questions about my cycle, performed a pelvic/vaginal exam and confirmed that there wasn't anything obviously wrong, and that I should come back if I was still bleeding in another two weeks. My copper IUD was ruled out as a possibile cause because it is not recent and it was still correctly  in place.   I believe there were two additional contributing factors: I came down with a cold and began experiencing symptoms the same day as I started bleeding. Those symptoms resolved within a week. I took one at-home rapid COVID test on day 2 of cold symptoms, which was negative. I also had just come out of an extended period of high stress due to a significant life event. However, I have been sick before and I have been under a high degree of stress before, but I have never had a period last longer than 7 days.
Neurology consult 2/13/21:  This is a 78-year-old female we were consulted by Dr. for possible guillian barre s/p COVID vaccine.  The patient tells me that she was in her normal state of health, and she received her 1st dose of the COVID-19 vaccineseen 7 days ago.  Subsequent to that, the next day she developed chills, fatigue that continued for approximately 2 days.  She states that 3 days ago, she woke up and was unable to lift her legs or get herself out of bed on her own.  She felt weak in her proximal lower extremities and her trunk.  She denied any bandlike sensations or paresthesias.  She cannot tell me that she developed any distal lower extremity weakness initially but felt that it was the acute onset.  She needed some help her out of bed when she was upright, she was able to use her walker to slowly get to the factor.  She may have had some urinary incontinence, she does complain of diarrhea now.   Denies any tingling sensation, no bulbar symptoms.  This is a 78-year-old female who we were asked to evaluate for possible Guillain-Barre syndrome.  She had acute onset of lower much greater than upper extremity weakness without any definite ascending features, of relevance, is that she received the COVID-19 vaccine 3 days prior to the onset of her symptoms.  She did exhibit flu-like symptoms prior to this.  Given that she does not have any specific area of intrathecal enhancement to suggest Guillain-Barre or other areas of radiculitis, I think it is reasonable to proceed with lumbar puncture to look for any other source.   --Given the findings on the MRI cervical and lumbar spine including enhancement of the bilateral sacral S1 region, I would like Neurosurgery to further evaluate. -- would likely benefit from CT chest abdomen pelvis to rule out any underlying occult malignancy particularly if workup remains unremarkable. -- continue supportive care, monitor for shortness of breath, new vital capacities  Patient remains admitted to the hospital with continued weakness at the time of this report
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of M-M-R II (dose, lot number and expiration date were not reported). On an unknown date, 26 days after receiving the first dose, the patient was vaccinated with the second dose of M-M-R II. No adverse effect was reported. Additional information has been requested.
Patient had vasovagal event at Vaccine clinic. LOC < 10 seconds, Reported feeling dizzy, nauseous, and lightheaded. Patient was laid down on cot, VSS. Laid for 10 min, sat with legs dangling for 10 minutes. Given  juice for sugar boost and water. Patient's mother present. States he has had episodes like this in the past. Patient is a vegetarian. Denies HA, difficulty breathing, SOB, CP.  1:08pm VS: BP: 84/62 O2: 98% HR: 52 -  laying  PERRLA, HRR, no vomiting.  1:13pm VS: 90/59, O2:98%, HR:54   Discharged at 1:30pm in stable condition in care of mother. Return/ED precautions given. -
Severe swelling, redness, warm to touch at injection site. No treatment necessary. Resolved on its own.
Woke up with my feet feeling like they were freezing cold, toes on left foot feeling some what numb and toes on right foot tingling like they were very cold BUT I WAS NOT COLD. Put feet next to heater, put on socks/shoes, walked around but not much better. Massaged feet often for several hours and around noon they started feeling normal although left big toe and the bottom of my toes still kind of tingly. I'm not a diabetic. My feet didn't feel cold to the touch; even when get next to heater I my feet felt the warmth of the heater but they still felt freezing cold, like the end of a day snow skiing.
Within 2 hours post vax the child seemed not to feel well, lethargic and increased sleep (2 Hours). One day post vax a rash began on tummy and continues to spread arms, palms and legs. Pt didn't  developed any in mouth or soles of feet. Described as red, raised circles (not hives) that itch with no fever.
Rash, itching. Local cellulitus at injection site. Given reflex antibiotics.
Sudden onset of aphasia on 11/15/21  @ approximately 10:00am. Brought to stroke center. Ct scan noted  Left middle cerebral artery occlusion. Received TPA  and thrombectomy by neuro interventional radiology. On 11/16 post MRI brain showed multiple small infarcts. Remained in ICU for 24 hours followed by monitoring Stroke unit for monitoring . Had echocardiogram and TEE on 11/18/21. No clots noted . Cardiology recommended placement of loop recorder d Discharged on 11/20/21. Placed on baby aspirin increased Lipitor
pt recv vax; devel a diffuse papular eruption fr head to toe that resembled allergic vax rxn;2 days later, subsided;
6 minutes after receiving vaccine patient reported that her tongue was starting to swell and that her heart was racing.  Staff called 911 immediately.  Pulse was 166-169, BP 125/88, O2 sat 97%.  No wheezing, and the patient was moving air and talking.  I had an epi-pen on hand but waited since patient was moving air and had such a high HR.  After a few minutes patient reported she felt better and that her tongue was still swollen but not any more so; HR 120s, O2 sat 97%.  EMTs arrived 10:39 a.m., got the same VS, and they decided not to give epinephrine.  Patient was initially reluctant to be transported by ambulance and intended to have sister drive her to ED.  However she reported her tongue was overlapping her teeth all the way around, and was persuaded to go by ambulance.  She walked out of public health clinic into ambulance.  She was treated with IV Benadryl and steroids.  The ED doctor diagnosed anaphylactic reaction but also did not give epinephrine due to tachycardia.  She felt better, but 4 hours afterward she did have a rebound reaction and was treated with more Benadryl and again felt better.  She was discharged from the ED with 2 epi-pens.  She currently feels well.  States that they are having her take PO Benadryl q 4 hours x 48 hours.  She was treated in the emergency department.
Pt developed GI upset on 7/31/01. Pt had increased temperature and diarrhea on 8/1/01. Pt continues to have severe diarrhea and was referred to physician for evaluation.
The vaccine given was expired. It's expiration date was 5/9/22 and the vaccine was administered on 5/18/22. The patient's guardian was contacted.
One hour after receiving the injection he began vomiting. He had no fever no symptoms prior. He vomited for 7 hours, then we were given a medication at the emergency room to stop the vomiting. He also complained of severe stomache pain which lasted 12 hours and then continued as mild pain for 12 additional hours.
pt reported bleeding from site of inject longer than other 2 injects; the injection burned while the nurse tried to work the medicine in; pt had fever, chest pain & SOB; arm was swollen pt took APAP;
Fever of 100.5; Body aches; Headache; Arm soreness; Dizziness; This is a spontaneous report from a contactable consumer (patient herself).  A 23-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 18Feb2021 13:30 (Batch/Lot Number: EL3247) (age at the vaccination 23-year-old) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient's historical vaccine included BNT162B2 (Batch/Lot number: EL3247) as dose 1, Arm Left single for covid-19 immunisation on 28Jan2021 01:30 PM (age at vaccination 23 years). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no Known allergies. On 18Feb2021 22:30, the patient had experienced fever of 100.5, body aches, headache, arm soreness and dizziness. The patient underwent lab tests and procedures which included body temperature: 100.5 on an unspecified date. The patient did not take treatment for the events. The outcome of events was recovered.   No follow-up attempts are possible. No further information is expected.
Don't believe that they help and sometimes I feel the make it worse with no reported adverse event/no AE; Initial information received on 27-Jan-2021 regarding an unsolicited valid serious case received from a consumer/non-healthcare professional.  This case involves a patient (unspecified age and gender) who had do not believe that they help and sometimes i feel the make it worse with no reported adverse event (vaccination failure), while he/she received vaccine INFLUENZA USP TRIVAL A-B WHOLE VIRION VACCINE [FLUZONE (WHOLE)].  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B WHOLE VIRION VACCINE [FLUZONE (WHOLE)] (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious did not believe that they help and sometimes i feel the make it worse with no reported adverse event (vaccination failure) unknown latency following the administration of INFLUENZA USP TRIVAL A-B WHOLE VIRION VACCINE. This event was assessed as medically significant.  It was a case of suspected vaccination failure.  No laboratory data was provided.  It was not reported if the patient received a corrective treatment.  Information on lot number for requested.; Sender's Comments: This case concerns a patient (unspecified age and gender) who reportedly had vaccination failure after vaccination with FLUZONE (WHOLE). The time to onset is unknown. Additional information regarding medical history, condition at the time of vaccination, lab data excluding other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Immediately felt dizziness and dry mouth.  Then within 2 hours felt extremely nauseated and fatigued.  For two days I felt shortness of breath and fatigue for 4-5 days.  The nausea lasted for over a week and then by the 4th day, diarrhea set in, which is now finally resolving after two weeks in.
Blood in the eye; Fever; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (Blood in the eye) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced OCULAR HYPERAEMIA (Blood in the eye) and PYREXIA (Fever). At the time of the report, OCULAR HYPERAEMIA (Blood in the eye) and PYREXIA (Fever) outcome was unknown.            No concomitant medications were reported.  No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not Applicable
Patient vomited multiple times about 5 minutes after receiving first dose of their pediatric Pfizer dose.  Had patient and parents wait for an additional 30 minutes post adverse event and they had no other issues.
16 month old male refused to bear out on right leg after Prevnar #4 injection 03/26/2003. Treated with heat and Motrin as well as warm compresses. 03/28/2002 Pulls to stand but will not walk. X-Ray right lowere extremity ne. 04/02/2003 walking normally , no Motrin DTRI , Muscle strength 4
he patient presents with SOB x a few days ago with associated fatigue. Pt was COVID-19 positive 1.5 weeks ago and had the Pfizer COVID-19 vaccine in March 2021. Pt was placed on 2L nasal cannula upon arrival to the ED and notes that her oxygen saturation was 84% on room air while at home. Diagnostic Impression:  Acute hypoxic respiratory failure due to COVID-19 pneumonia  Bilateral viral COVID-19 pneumonia  Mild dehydration  History of hypertension  History of fatal arrhythmia status post AICD placement  COVID-19 vaccinated, March 2021, Pfizer
Fever; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jun-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). On 13-Jun-2021, PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) had resolved.            No relevant concomitant medication was reported. Treatment information was not provided.   This case was linked to MOD-2021-223907 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow up received contains no new information.
Shortly after getting vaccinated, patient sat down for a 15 min wait period. She immediately started having trouble breathing and complained of stomach pain and a desire to vomit. I took her to the bathroom, she started getting hot, complained that it was getting harder to breathe, and seemed a little confused/didn't register what I was saying to keep her calm and wanting her to get out of the bathroom so we could speak with the pharmacist for help. I got her out, and the pharmacist helped me to refill her albuterol prescription (she needs it so rarely, when she has a cold, we didn't have it with us + she's never had an adverse reaction to a vaccine). That helped immediately. She drank some water. She then went back to the bathroom and had diarrhea. After that, we hung out for another 30+ minutes. Her breathing stabilized, she didn't need more albuterol, and she said she felt much better.  We're still less than 12 hrs. out from the vaccine as I write, so we are monitoring for any symptoms, and encouraging her to rest and drink fluids. I've also contacted her dr. to give a heads up.
Itchiness all over body and hives. Awaken with severe symptoms as above at 12:05 AM 12/3/03. Took Benadryl 50mg, went to sleep. Woke in morning with mild symptoms until mid morning and started itching again. ER - Solumedrol IV, Benadryl 25mg, Tagament IV.